Damien Roos‐Weil

3.4k total citations
82 papers, 896 citations indexed

About

Damien Roos‐Weil is a scholar working on Genetics, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Damien Roos‐Weil has authored 82 papers receiving a total of 896 indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Genetics, 28 papers in Pathology and Forensic Medicine and 23 papers in Oncology. Recurrent topics in Damien Roos‐Weil's work include Chronic Lymphocytic Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (28 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Damien Roos‐Weil is often cited by papers focused on Chronic Lymphocytic Leukemia Research (38 papers), Lymphoma Diagnosis and Treatment (28 papers) and Immunodeficiency and Autoimmune Disorders (12 papers). Damien Roos‐Weil collaborates with scholars based in France, United States and Germany. Damien Roos‐Weil's co-authors include Véronique Leblond, Olivier Bernard, Florence Nguyen‐Khac, Stéphanie Nguyen, Pierre Pothier, Katia Ambert‐Balay, Vincent Vieillard, Fanny Lanternier, Marc Lecuit and Marie‐France Mamzer and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Damien Roos‐Weil

73 papers receiving 882 citations

Peers

Countries citing papers authored by Damien Roos‐Weil

Since Specialization

Citations

This map shows the geographic impact of Damien Roos‐Weil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damien Roos‐Weil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damien Roos‐Weil more than expected).

Fields of papers citing papers by Damien Roos‐Weil

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Damien Roos‐Weil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damien Roos‐Weil. The network helps show where Damien Roos‐Weil may publish in the future.

Co-authorship network of co-authors of Damien Roos‐Weil

This figure shows the co-authorship network connecting the top 25 collaborators of Damien Roos‐Weil. A scholar is included among the top collaborators of Damien Roos‐Weil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Damien Roos‐Weil. Damien Roos‐Weil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	ICE polychemotherapy is an efficient salvage treatment in primary central nervous system lymphoma: an LOC network study 2025 ·Blood Advances ·Louis Pérol, (unknown), Carole Soussain, Khê Hoang‐Xuan, (unknown), Marine Baron, Véronique Morel, Nabih Azar, (unknown), Madalina Uzunov, Magali Le Garff‐Tavernier, Laëtitia Souchet, Nicolas Gauthier, Marie‐Pierre Moles‐Moreau, Thomas Gastinne, Caroline Houillier, Sylvain Choquet, Damien Roos‐Weil	1
2	Bortezomib, Rituximab and Dexamethasone Regimen (BDR) in Waldenström Macroglobulinaemia: A Retrospective Real‐World Analysis 2025 ·eJHaem ·Thomas Hueso, Grégory Lazarian, (unknown), Adrien Chauchet, Ramy Rahmé, Sabine Bréchignac, Vincent Lévy, Salomon Manier, Damien Roos‐Weil, David Ghez, Claude Gardin, Fanny Baran‐Marszak, Éric Durot, Pierre Morel, Thorsten Braun	0
3	Report of Consensus Panel 2 from the 12th International Workshop on the management of Bing-Neel syndrome in patients with Waldenstrom’s Macroglobulinemia 2025 ·Seminars in Hematology ·Shayna Sarosiek, (unknown), Andrew R. Branagan, Simone Ferrero, Jahanzaib Khwaja, Eva Kimby, Damien Roos‐Weil, Naohiro Sekiguchi, Marek Trněný, Shuhua Yi, Christopher J. Patterson, Christian Buske, Jeffrey Matous, Steven P. Treon, Monique C. Minnema	0
4	Report of Consensus Panel 6 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on Diagnosis and Management of Transformed Waldenstrom's Macroglobulinemia 2025 ·Seminars in Hematology ·Éric Durot, Jithma P. Abeykoon, Damien Roos‐Weil, (unknown), Charalampia Kyriakou, David F. Moreno, Stephen M. Ansell, Rebecca Auer, Xinxin Cao, Roger G. Owen, Shuhua Yi, Irene Dogliotti, Marek Trněný, Christopher J. Patterson, Jeffrey Matous, Christian Buske, Steven P. Treon, Ranjana H. Advani	1
5	Six-year follow-up of phase II study exploring chemo-free treatment association with idelalisib and obinutuzumab in symptomatic relapsed/ refractory patients with Waldenström’s macroglobulinemia 2024 ·Annals of Hematology ·Cécile Tomowiak, Stéphanie Poulain, (unknown), Pierre Feugier, Charles Herbaux, Beatrice Mahé, Pierre Morel, Thérèse Aurran, Olivier Tournilhac, Stéphane Leprêtre, Souad Assaad, Bruno Villemagne, Olivier Casasnovas, (unknown), Damien Roos‐Weil, José Miguel Torregrosa Diaz, Sylvie Chevret, Véronique Leblond, (unknown)	2
6	Invasive Aspergillosis with impaired neutrophil responses against Aspergillus fumigatus in patients treated with Acalabrutinib—findings from three cases 2024 ·International Journal of Infectious Diseases ·Marion Blaize, (unknown), Alexandre Boissonnas, (unknown), Fanny Lanternier, (unknown), Felipe Suarez, Marie‐Elisabeth Bougnoux, J. Guitard, Arnaud Jabet, Nicolas Stocker, (unknown), Damien Roos‐Weil, Arnaud Fekkar	5
7	Long‐term results of Waldenström macroglobulinaemia treatment by bendamustine and rituximab: A study on behalf of the French Innovative Leukemia Organization (FILO) 2024 ·British Journal of Haematology ·Kamel Laribi, Stéphanie Poulain, Lise Willems, Fatiha Merabet, Charles Herbaux, Damien Roos‐Weil, (unknown), Xavier Roussel, (unknown), Sabine Tricot, Jehan Dupuis, Ronan Le Calloch, Benoît Bareau, Véronique Leblond	6
8	Limited efficacy for ibrutinib and venetoclax in T-prolymphocytic leukemia: results from a phase 2 international study 2024 ·Blood Advances ·Marco Herling, Claire Dearden, Francesco Zaja, Dima El‐Sharkawi, Wei Ding, Mar Bellido, Amit Khot, Lidwine W. Tick, Eric D. Jacobsen, Toby A. Eyre, Damien Roos‐Weil, (unknown), Elisa Lucchini, Natali Pflug, Matthew S. Davids, (unknown), Nabanita Mukherjee, Mohamed Badawi, (unknown), Philipp B. Staber	2
9	High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia 2024 ·Blood ·Éric Durot, Damien Roos‐Weil, Adrien Chauchet, Justine Decroocq, Roberta Di Blasi, Thomas Gastinne, (unknown), Morgane Cheminant, (unknown), Stéphanie Guidez, François‐Xavier Gros, Emmanuel Bachy, (unknown), Pascale Cony‐Makhoul, Steven P. Treon, Alain Delmer, Ran Reshef, Steven Le Gouill, Jorge J. Castillo, Roch Houot	3
10	Splenectomy allows remission of angioedema with acquired C1-inhibitor deficiency associated with splenic marginal zone lymphoma 2024 ·The Journal of Allergy and Clinical Immunology In Practice ·Simon Valayer, Federica Defendi, Carine El Sissy, Damien Roos‐Weil, Félix Ackermann, Laurence Bouillet, Isabelle Boccon‐Gibod, Paul Coppo, Najim Chafaı̈, (unknown), Chloé McAvoy, O. Fain, Delphine Gobert	0
11	Epigenetic features support the diagnosis of B-cell prolymphocytic leukemia and identify 2 clinicobiological subtypes 2024 ·Blood Advances ·(unknown), Élise Chapiro, Ferran Nadeu, Thorsten Zenz, Sı́lvia Beà, (unknown), Marta Aymerich, Marı́a Rozman, Damien Roos‐Weil, Olivier Bernard, Santos A. Susín, Helen Parker, Renata Walewska, Christopher C. Oakes, Jonathan C. Strefford, Elı́as Campo, Estella Matutes, Martí Duran‐Ferrer, Florence Nguyen‐Khac, José I. Martı́n-Subero	1
12	Combining MYD88 L265P mutation detection and clonality determination on CSF cellular and cell‐free DNA improves diagnosis of primary CNS lymphoma 2023 ·British Journal of Haematology ·(unknown), (unknown), Marine Armand, Élise Sourdeau, Karima Mokhtari, Karim Maloum, (unknown), (unknown), Caroline Houillier, Damien Roos‐Weil, Carole Soussain, Sylvain Choquet, Khê Hoang‐Xuan, Magali Le Garff‐Tavernier, Jérôme Alexandre Denis, Frédéric Davi	12
13	del(8p) and TNFRSF10B loss are associated with a poor prognosis and resistance to fludarabine in chronic lymphocytic leukemia 2023 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), (unknown), Frédéric Davi, Letícia Koch Lerner, Delphine Garnier, (unknown), Olivier Tournilhac, Damien Roos‐Weil, Marouane Boubaya, Élise Chapiro, Santos A. Susín, Florence Nguyen‐Khac	2
14	Acute myeloid leukaemia following direct acting antiviral drugs in HCV-infected patients: A 10 years’ retrospective single-center study 2022 ·Clinics and Research in Hepatology and Gastroenterology ·(unknown), (unknown), Bénédicte Lebrun‐Vignes, (unknown), Dominique Thabut, Damien Roos‐Weil, Agnès Dechartres, (unknown)	0
15	Immunochemotherapy versus rituximab in anti‐myelin‐associated glycoprotein neuropathy: A report of 64 patients 2022 ·British Journal of Haematology ·(unknown), Amandine Baptiste, Lisa Belin, Pascale Ghillani‐Dalbin, (unknown), Sylvain Choquet, Thierry Lamy, Véronique Morel, Lucile Musset, Damien Roos‐Weil, Karine Viala, Véronique Leblond, Marine Baron	4
16	Cytogenetic and molecular abnormalities in Waldenström's macroglobulinemia patients: Correlations and prognostic impact 2021 ·American Journal of Hematology ·(unknown), (unknown), (unknown), Marine Baron, (unknown), Frédéric Davi, Marine Armand, (unknown), Jonathan Caron, Olivier Bernard, Santos A. Susín, Élise Chapiro, Véronique Leblond, Florence Nguyen‐Khac, Damien Roos‐Weil	24
17	Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard? 2021 ·Journal of Neurology ·Damien Roos‐Weil, Nicolas Weiss, Amélie Guihot, Madalina Uzunov, Agnès Bellanger, B. Eymard, David Saadoun, Caroline Houillier, Ahmed Idbaïh, Sophie Demeret, Claire Deback, Véronique Leblond, Damien Galanaud, Natalia Shor, Valérie Pourcher	11
18	Successful treatment of an EBV‐positive HIV‐associated polymorphic B‐cell lymphoproliferative disorder by rituximab monotherapy 2021 ·SHILAP Revista de lepidopterología ·Mohamad Sabbah, Sylvain Choquet, (unknown), (unknown), Marine Baron, Frédéric Charlotte, Damien Roos‐Weil	2
19	High frequency of clonal hematopoiesis in Erdheim-Chester disease 2020 ·Blood ·Fleur Cohen‐Aubart, Damien Roos‐Weil, Marine Armand, Alice Marceau‐Renaut, Jean‐François Emile, Nicolas Duployez, Frédéric Charlotte, Stéphanie Poulain, Raphaël Lhote, Zofia Hélias‐Rodzewicz, Véronique Della-Valle, Olivier Bernard, Karim Maloum, Florence Nguyen‐Khac, Jean Donadieu, Zahir Amoura, Omar Abdel‐Wahab, Julien Haroche	36
20	Identification of two DNA methylation subtypes of Waldenström's macroglobulinemia with plasma and memory B cell features 2020 ·Blood ·Damien Roos‐Weil, Brian Giacopelli, Marine Armand, Véronique Della-Valle, Hussein Ghamlouch, (unknown), Marlen Metzner, Junyan Lu, Magali Le Garff‐Tavernier, Véronique Leblond, Paresh Vyas, Thorsten Zenz, Florence Nguyen‐Khac, Olivier Bernard, Christopher C. Oakes	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact